Building Code and Medicine Notices




NEW ZEALAND GAZETTE, No. 102 — 5 OCTOBER 2017

replaced by the material in Column 2:

Column 1 Column 2
NZS 3101.1:2006 Amend: 1, 2 NZS 3101.1:2006 Amend: 1, 2, 3

Copies and Viewing of the Proposals for the Changes

The statements of proposal for the changes to the Verification Method B1/VM1, the proposed ban and the material incorporated by reference in the Verification Method B1/VM1, can be downloaded free of charge from the Ministry’s website: www.mbie.govt.nz/info-services/building-construction/consultations.

The statements of proposal are also available from the Wellington office of the Ministry at 15 Stout Street, Wellington, between the hours of 8.30am and 5.00pm, Monday to Friday.

Purchase of Material Incorporated by Reference

The material incorporated by reference described above may be purchased directly from:

  • Standards New Zealand, Ministry of Business, Innovation and Employment, 15 Stout Street, Wellington 6011, or online at www.standards.govt.nz.
  • BSI New Zealand Limited, Level 10, 21 Queen Street, Auckland 1010, or online at www.bsigroup.com/en-NZ.

Viewing Materials Incorporated by Reference

Materials incorporated by reference are available for inspection free of charge at the Ministry’s Wellington office between the hours of 8.30am and 5.00pm, Monday to Friday.

To make an appointment to view material incorporated by reference, call 0800 242 243.

Submissions

I invite submissions on the proposals contained in this notice by 20 November 2017. Submissions can be made in the following ways:

  • By email to buildingfeedback@mbie.govt.nz with "Consultation – Feedback – Consultation – Amendments to B1/VM1 and Loop Bar Connection Ban 2017" in the subject line; or
  • By courier or post to Consultation–Feedback–Amendments to B1/VM1 and Loop Bar Connection Ban 2017, Ministry of Business, Innovation and Employment, 15 Stout Street (PO Box 1473), Wellington 6140, attention: Bruce Klein.

Dated at Wellington this 5th day of October 2017.

ANNA BUTLER, General Manager, Ministry of Business, Innovation and Employment.

2017-go5132

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Abstral

Active Ingredient: Fentanyl citrate 157.1mcg equivalent to fentanyl 100mcg

Dosage Form: Sublingual tablet

New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics

Manufacturer: Aesica Queenborough Limited, Queenborough, United Kingdom

Product: Abstral

Active Ingredient: Fentanyl citrate 314.2mcg equivalent to fentanyl 200mcg

Dosage Form: Sublingual tablet

New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics

Manufacturer: Aesica Queenborough Limited, Queenborough, United Kingdom

59



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2017, No 102





✨ LLM interpretation of page content

🏗️ Proposed Amendments to Building Code Verification Method B1/VM1 and Ban on Loop Bar Hanger Connection Detail (continued from previous page)

🏗️ Infrastructure & Public Works
5 October 2017
Building Code, Verification Method B1/VM1, Loop Bar Hanger Connection Detail, Building Act 2004, Ministry of Business, Innovation and Employment
  • Anna Butler, General Manager, Ministry of Business, Innovation and Employment

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
Medicines Act 1981, Abstral, Fentanyl citrate, Pharmacy Retailing (NZ) Limited, Aesica Queenborough Limited